Onodera, O. Triheptanoin treatment in ataxia-telangiectasia: The significance of innovative clinical trials targeting mitochondrial dysfunction. Elsevier.
Chicago Style (17th ed.) CitationOnodera, Osamu. Triheptanoin Treatment in Ataxia-telangiectasia: The Significance of Innovative Clinical Trials Targeting Mitochondrial Dysfunction. Elsevier.
MLA (9th ed.) CitationOnodera, Osamu. Triheptanoin Treatment in Ataxia-telangiectasia: The Significance of Innovative Clinical Trials Targeting Mitochondrial Dysfunction. Elsevier.
Warning: These citations may not always be 100% accurate.